Mode
Text Size
Log in / Sign up

Early life social isolation stress may contribute to nociplastic pain development, but causal pathways remain unclear

Early life social isolation stress may contribute to nociplastic pain development, but causal…
Photo by National Cancer Institute / Unsplash
Key Takeaway
Consider that early life social isolation stress may be a risk factor for nociplastic pain, but causal links are not established.

This is a narrative review that outlines a conceptual model linking early life social isolation stress to the development of nociplastic pain. The authors synthesize evidence from indirect, model-dependent, and related lines of research, noting that much of this evidence derives from studies on stress-related conditions, neuroinflammation, and disorders such as fibromyalgia, rather than being specific to nociplastic pain per se. The central argument is that early life social isolation stress may contribute to nociplastic pain, but the relationship remains incompletely understood. Key limitations acknowledged by the authors include that causal pathways remain to be clarified and that the evidence is largely inferred from related research. The review aims to outline a conceptual model that may help guide future research and inform therapeutic strategies, but it does not provide specific practice recommendations due to the preliminary nature of the evidence.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Chronic pain is increasingly recognized as a multidimensional condition in which neuroimmune interactions shape disease vulnerability and persistence. Among the emerging pain phenotypes, nociplastic pain (defined as an alteration of nociceptive processing in the absence of clear tissue damage or somatosensory lesion) remains mechanistically elusive and therapeutically challenging. Emerging evidence suggests that early life stress, particularly social isolation, may be a potent psychosocial stressor associated with an increased risk of nociplastic pain. However, this relationship remains incompletely understood and is largely inferred from indirect, model-dependent, or related lines of research. Preclinical and clinical studies indicate that prolonged social isolation can induce sustained activation of the hypothalamic–pituitary–adrenal (HPA) axis, systemic low-grade inflammation, and immune changes. These changes have been shown to promote persistent microglial activation, astrocytic reactivity, and dysregulated neuron–glia communication within pain-processing regions, including the spinal dorsal horn and supraspinal affective circuits. In parallel, peripheral neuroimmune alterations, particularly involving satellite glial cells and Schwann cells may contribute to increased sensory neuron excitability and processes consistent with central sensitization. Notably, much of this evidence derives from studies on stress-related conditions, neuroinflammation, and disorders such as fibromyalgia, rather than being specific to nociplastic pain per se. Early life social isolation stress has also been associated with changes in limbic and prefrontal networks implicated in the affective components of pain, suggesting a potential interaction between emotional dysregulation and pain amplification, although causal pathways remain to be clarified. Sex-dependent differences in neuroimmune signalling further add complexity to this framework, suggesting that biological sex may influence vulnerability to isolation-induced pain states and response to glial-targeted interventions. This narrative review proposes a putative neuroimmune model linking early life social isolation stress to nociplastic pain vulnerability and persistence. By integrating evidence from stress biology, glial dysfunction, and central sensitization, we aim to outline a conceptual model that may help guide future research and inform therapeutic strategies targeting central and peripheral neuroinflammatory processes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.